Don Williamson
Research Subjects
Research Interests
Don Williamson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alexandru I. Costea
The Christ Hospital, Cincinnati, Ohio
1 shared publication- Bruce A. Koplan
Brigham and Women's Hospital, Cardiovascular Division, Boston, Massachusetts, USA
1 shared publication - Candace K. McClure
North American Science Associates, Minneapolis, USA
1 shared publication - David M. Charytan
Department of Medicine, New York University, New York, New York
1 shared publication Finnian R. Mc Causland
Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts
1 shared publicationJames A. Tumlin
NephroNet Clinical Research Consortium, Atlanta, Georgia
1 shared publication
Latest Publications
- Open Access
- 6 August 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (10) , 1490-1499
Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study
Key Points: Sudden cardiac death is a major concern for hemodialysis patients. Mortality is higher on dialysis days and is associated with higher dialysate bicarbonate (DBIC). Contrary to our hypothesis, there was no consistent association of higher DBIC with a higher risk of arrhythmia. Further research is needed to assess the optimal DBIC and mechanisms by which it may improve outcomes for maintenance hemodialysis patients. Background: Sudden death accounts for approximately 25% of deaths among maintenance hemodialysis patients, occurring more frequently on hemodialysis days. Higher dialysate bicarbonate (DBIC) may predispose to alkalemia and arrhythmogenesis. Methods: We conducted a 12-month analysis of session-level data from 66 patients with implantable loop recorders. We fit logistic regression and negative binomial mixed-effects regression models to assess the association of DBIC with clinically significant arrhythmia (ventricular tachycardia ≥115 beats per minute [BPM] for at least 30 seconds, bradycardia ≤40 BPM for at least 6 seconds, or asystole for at least 3 seconds) and reviewer confirmed arrhythmia (RCA—implantable loop recorder-identified or patient-marked event for which a manual review of the stored electrocardiogram tracing confirmed the presence of atrial fibrillation, supraventricular tachycardia, sinus tachycardia with rate >130 BPM, ventricular tachycardia, asystole, or bradycardia). Models adjusted for age, sex, race, hemodialysis vintage, vascular access, and prehemodialysis serum bicarbonate and additionally for serum and dialysate potassium levels. Results: The mean age was 56±12 years, 70% were male, 53% were Black, and 35% were Asian. Fewer RCA episodes were associated with DBIC >35 than 35 mEq/L (incidence rate ratio 0.45 [0.27 to 0.75] and adjusted incident rate ratio 0.54 [0.30 to 0.97]), but the association was not significant when adjusting for serum and dialysate potassium levels (adjusted incident rate ratio, 0.60 [0.32 to 1.11]). Otherwise, no associations between DBIC and arrhythmia were identified. Conclusions: We observed a lower frequency of RCA with higher DBIC, compared with DBIC of 35 mEql/L, contrary to our original hypothesis, but this association was attenuated in fully adjusted models. Validation of these findings in larger studies is required, with a further need for interventional studies to explore the optimal DBIC concentration.
- 6 August 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (10) , 1490-1499
Open AccessAssociation of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study
Key Points: Sudden cardiac death is a major concern for hemodialysis patients. Mortality is higher on dialysis days and is associated with higher dialysate bicarbonate (DBIC). Contrary to our hypothesis, there was no consistent association of higher DBIC with a higher risk of arrhythmia. Further research is needed to assess the optimal DBIC and mechanisms by which it may improve outcomes for maintenance hemodialysis patients. Background: Sudden death accounts for approximately 25% of deaths among maintenance hemodialysis patients, occurring more frequently on hemodialysis days. Higher dialysate bicarbonate (DBIC) may predispose to alkalemia and arrhythmogenesis. Methods: We conducted a 12-month analysis of session-level data from 66 patients with implantable loop recorders. We fit logistic regression and negative binomial mixed-effects regression models to assess the association of DBIC with clinically significant arrhythmia (ventricular tachycardia ≥115 beats per minute [BPM] for at least 30 seconds, bradycardia ≤40 BPM for at least 6 seconds, or asystole for at least 3 seconds) and reviewer confirmed arrhythmia (RCA—implantable loop recorder-identified or patient-marked event for which a manual review of the stored electrocardiogram tracing confirmed the presence of atrial fibrillation, supraventricular tachycardia, sinus tachycardia with rate >130 BPM, ventricular tachycardia, asystole, or bradycardia). Models adjusted for age, sex, race, hemodialysis vintage, vascular access, and prehemodialysis serum bicarbonate and additionally for serum and dialysate potassium levels. Results: The mean age was 56±12 years, 70% were male, 53% were Black, and 35% were Asian. Fewer RCA episodes were associated with DBIC >35 than 35 mEq/L (incidence rate ratio 0.45 [0.27 to 0.75] and adjusted incident rate ratio 0.54 [0.30 to 0.97]), but the association was not significant when adjusting for serum and dialysate potassium levels (adjusted incident rate ratio, 0.60 [0.32 to 1.11]). Otherwise, no associations between DBIC and arrhythmia were identified. Conclusions: We observed a lower frequency of RCA with higher DBIC, compared with DBIC of 35 mEql/L, contrary to our original hypothesis, but this association was attenuated in fully adjusted models. Validation of these findings in larger studies is required, with a further need for interventional studies to explore the optimal DBIC concentration.